Pharmaceutical Industry Information Portal

ChemRar invests one billion rubles in a new plant for the production of pharmaceutical substances in Khimki

Construction is expected to be fully completed by the end of 2024, with full production start-up scheduled for Q1-Q2 2025.

ALIUM expands production of granulated preparations

Pharmaceutical plant ALIUM, part of Binnopharm Group, is preparing to implement a new ambitious project to expand pharmaceutical production, which will significantly increase the output of granulated drugs.

GEROPHARM is going to develop biomedicine and pharmacology in the Russian Far East

GEROPHARM has signed two trilateral cooperation agreements on the IX Eastern Economic Forum, which is taking place from 3 to 6 September in Vladivostok.

The EEC Collegium approved amendments to the rules for determining OTC categories of medicines

According to the source, the general criteria for classifying drugs as OTC have been supplemented with special criteria for individual active substances.

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...

FDA approves Sanofi’s Dupixent for widespread use in the United States

Sanofi won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the...

Radiopharmaceuticals Production Complex Built by Rosatom Starts Medical Supplies to Bolivian clinics

A unique for Latin America complex for radiopharmaceuticals production buit by Rosatom by order of the Bolivian Nuclear Energy...

Binnopharm Group brings its popular antispasmodic to Azerbaijan

Binnopharm Group, a pharmaceutical company and part of Sistema, continues to expand its footprint in the CIS markets. Neobutin,...

Amgen sells its Turkish manufacturing arm for $135M

Amgen, which has been beefing up its U.S. manufacturing operations, sold its stake in Turkey’s oldest pharmaceutical company Gensenta...

Don’t miss your daily PharmProm news.
SUBSCRIBE free here!

GMP-inspections of veterinary manufacturers in the third quarter of 2024

The review for the third quarter of 2024 provides information on the inspection of manufacturers of veterinary medicines for...

GMP-inspections of veterinary manufacturers in the second quarter of 2024

The review for the second quarter of 2024 provides information on the inspection of manufacturers of veterinary medicines for compliance with the requirements of the Good Manufacturing Practice (GMP).

GMP-inspections of veterinary manufacturers in the first qarter of 2024

The quarterly review provides information on the inspection of manufacturers of veterinary medicines for compliance with the requirements of...

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...

Sanofi-GSK’s Covid vaccine, effective against omicron, could hit the market this year

Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta...

OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures

OSE Immunotherapeutics SA today announces that the Company is one of the first biotech startup companies selected by Microsoft...

Pharmaceutical Drug Production in Russia (June, January–June 2023)

In January–June 2023, Russian manufacturers produced 342.5 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 2.6% from the same period in 2022.

RNC Pharma: Pharmaceutical Drug Production in Russia (May 2023)

In January–May 2023, Russian manufacturers produced 282 billion rubles’ of pharmaceutical drugs (manufacturer’s prices, VAT included), down 5.8% from the same period in 2022.

RNC Pharma: Top 20 Online Pharmaceutical Retailers in Russia in Q1 2023

In January–March 2023, the online sales or reservations of pharmacy products (pharmaceutical drugs and parapharmaceuticals) in Russia were 80.2 billion rubles (end-user prices, VAT included), up 2.3% from January–March 2022 (against 69.6% in Q1 2022, with its rush demand).